<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PMDA - Irubas Pharma Regulatory Portal</title>
  <style>
    body {
      margin: 0;
      font-family: Arial, sans-serif;
      background: #f8f9fa;
    }

    /* Header */
    header {
      background-color: #d4e7f7;
      display: flex;
      align-items: center;
      padding: 10px 30px;
      border-bottom: 2px solid #b0cbea;
    }

    header img {
      height: 50px;
      margin-right: 15px;
    }

    header h1 {
      font-size: 26px;
      color: #003366;
      margin: 0;
      font-weight: bold;
    }

    /* Second bar */
    .sub-header {
      background-color: #b0cbea;
      color: #003366;
      display: flex;
      align-items: center;
      justify-content: flex-start;
      padding: 10px 30px;
      font-weight: bold;
      border-bottom: 1px solid #9cbadd;
      font-size: 20px;
    }

    .sub-header img {
      height: 50px;
      margin-right: 15px;
    }

    .sub-header span {
      font-size: 18px;
      font-weight: bold;
    }

    .home-icon {
      height: 35px;
      width: 35px;
      margin-right: 20px;
      cursor: pointer;
    }

    /* Third line */
    nav {
      background-color: #d4e7f7;
      display: flex;
      justify-content: center;
      gap: 45px;
      padding: 14px 0;
      font-weight: bold;
      border-bottom: 2px solid #aac3de;
    }

    nav a {
      text-decoration: none;
      color: #003366;
      font-size: 16px;
      position: relative;
      transition: all 0.3s ease;
    }

    nav a:hover {
      color: #001f4d;
    }

    nav a::after {
      content: "";
      position: absolute;
      bottom: -6px;
      left: 0;
      width: 0%;
      height: 2px;
      background-color: #003366;
      transition: width 0.3s ease;
    }

    nav a:hover::after {
      width: 100%;
    }

    /* Content section */
    .content {
      max-width: 1000px;
      margin: 40px auto;
      background-color: #ffffff;
      padding: 30px;
      border-radius: 10px;
      box-shadow: 0 2px 6px rgba(0,0,0,0.1);
      line-height: 1.8;
      color: #333;
    }

    h2 {
      color: #003366;
      border-bottom: 2px solid #aac3de;
      padding-bottom: 5px;
    }

    .faq {
      margin-top: 40px;
    }

    details {
      margin: 10px 0;
      background-color: #f4f7fb;
      padding: 10px;
      border-left: 4px solid #0055aa;
      border-radius: 4px;
    }

    summary {
      font-weight: bold;
      cursor: pointer;
      color: #003366;
    }

    p {
      margin: 10px 0 0 10px;
    }
  </style>
</head>
<body>

  <!-- First line -->
  <header>
    <img src="irubas-logo.png" alt="Irubas Logo">
    <h1>IRUBAS</h1>
  </header>

  <!-- Second line -->
  <div class="sub-header">
    <a href="index.html"><img src="home.png" alt="Home" class="home-icon"></a>
    <img src="pmda-logo.png" alt="PMDA Logo">
    <div>
      PMDA <span>(Pharmaceuticals and Medical Devices Agency - Japan)</span>
    </div>
  </div>

  <!-- Third line -->
  <nav>
    <a href="https://www.pmda.go.jp/english/" target="_blank">PMDA OFFICIAL SITE</a>
    <a href="https://www.pmda.go.jp/english/review-services/index.html" target="_blank">REVIEW SERVICES</a>
    <a href="https://www.pmda.go.jp/english/safety/index.html" target="_blank">SAFETY INFORMATION</a>
    <a href="https://www.pmda.go.jp/english/regulations/index.html" target="_blank">REGULATIONS</a>
    <a href="https://www.pmda.go.jp/english/rs-sb-std/index.html" target="_blank">STANDARDS & GUIDELINES</a>
    <a href="https://www.pmda.go.jp/english/about-pmda/index.html" target="_blank">ABOUT PMDA</a>
  </nav>

  <!-- Content -->
  <div class="content">
    <h2>About PMDA</h2>
    <p>The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory body responsible for ensuring the safety, efficacy, and quality of pharmaceuticals and medical devices. It operates under the Ministry of Health, Labour and Welfare (MHLW).</p>

    <p>PMDA provides consultation, conducts reviews of new drug applications, monitors adverse effects, and ensures post-marketing surveillance to maintain high safety standards for healthcare products in Japan.</p>

    <h2>Main Responsibilities</h2>
    <ul>
      <li>Evaluate applications for pharmaceuticals and medical devices for marketing authorization in Japan.</li>
      <li>Ensure post-marketing surveillance and safety monitoring of approved products.</li>
      <li>Provide guidance and scientific consultation during product development.</li>
      <li>Collaborate with MHLW and international organizations to align regulatory standards.</li>
      <li>Promote research in regulatory science and patient safety initiatives.</li>
    </ul>

    <div class="faq">
      <h2>Frequently Asked Questions</h2>
      <details>
        <summary>What is PMDA’s role in Japan’s healthcare system?</summary>
        <p>PMDA evaluates and monitors pharmaceuticals and medical devices to ensure they are safe and effective before and after marketing authorization.</p>
      </details>
      <details>
        <summary>Does PMDA provide scientific advice to companies?</summary>
        <p>Yes, PMDA offers scientific consultation services during product development to improve the quality and success of applications.</p>
      </details>
      <details>
        <summary>What does PMDA do after a product is approved?</summary>
        <p>PMDA conducts post-marketing surveillance and collects data on safety and efficacy to ensure continued product quality and performance.</p>
      </details>
      <details>
        <summary>Does PMDA collaborate internationally?</summary>
        <p>Yes, PMDA works with international agencies such as the USFDA, EMA, and WHO to harmonize global regulatory standards.</p>
      </details>
    </div>
  </div>

</body>
</html>
